{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:20:53Z","timestamp":1793391653785,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,26]]},"DOI":"10.7759\/cureus.72443","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T21:13:33Z","timestamp":1729977213000},"source":"Crossref","is-referenced-by-count":9,"title":["An Integrated Pathophysiological and Clinical Perspective of the Synergistic Effects of Obesity, Hypertension, and Hyperlipidemia on Cardiovascular Health: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Pedro","family":"Okoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damilare A","family":"Olusanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu C","family":"Erinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosisochi E","family":"Achara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun O","family":"Aboaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejoice","family":"Abiodun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A","family":"Gbigbi-Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejoice F","family":"Abiodun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebimpe","family":"Oredugba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dieba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okelue E","family":"Okobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills KT","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020, 16:223-37. 10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-167","article-title":"Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia","volume":"9","author":"Esteghamati A","year":"2009","unstructured":"Esteghamati A, Meysamie A, Khalilzadeh O, et al.. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009, 9:167. 10.1186\/1471-2458-9-167","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Aguilar D, Deswal A, et al.. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016, 134:e535-78. 10.1161\/CIR.0000000000000450","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02491-2","article-title":"Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China","volume":"22","author":"Wang C","year":"2022","unstructured":"Wang C, Du Z, Ye N, Shi C, Liu S, Geng D, Sun Y. Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China. BMC Cardiovasc Disord. 2022, 22:47. 10.1186\/s12872-022-02491-2","journal-title":"BMC Cardiovasc Disord"},{"key":"ref5","unstructured":"Obesity and overweight. (2024). Accessed. 10\/10\/2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2012.11.003","article-title":"Hyperlipidemia as a risk factor for cardiovascular disease","volume":"40","author":"Nelson RH","year":"2013","unstructured":"Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013, 40:195-211. 10.1016\/j.pop.2012.11.003","journal-title":"Prim Care"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2014.44","article-title":"The pathophysiology of hypertension in patients with obesity","volume":"10","author":"DeMarco VG","year":"2014","unstructured":"DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014, 10:364-76.","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2013.11.001","article-title":"Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease","volume":"35","author":"Mohamed S","year":"2014","unstructured":"Mohamed S. Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease. Trends Food Sci Technol. 2014, 35:114-28. 10.1016\/j.tifs.2013.11.001","journal-title":"Trends Food Sci Technol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-019-0165-6","article-title":"A step by step guide for conducting a systematic review and meta-analysis with simulation data","volume":"47","author":"Tawfik GM","year":"2019","unstructured":"Tawfik GM, Dila KA, Mohamed MY, Tam DN, Kien ND, Ahmed AM, Huy NT. A step by step guide for conducting a systematic review and meta-analysis with simulation data. Trop Med Health. 2019, 47:46. 10.1186\/s41182-019-0165-6","journal-title":"Trop Med Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nature25753","article-title":"Meta-analysis and the science of research synthesis","volume":"555","author":"Gurevitch J","year":"2018","unstructured":"Gurevitch J, Koricheva J, Nakagawa S, Stewart G. Meta-analysis and the science of research synthesis. Nature. 2018, 555:175-82. 10.1038\/nature25753","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2021.04.002","article-title":"Ensuring Rigor in systematic reviews: part 5, quality appraisal, data extraction, synthesis","volume":"50","author":"Batten J","year":"2021","unstructured":"Batten J, Brackett A. Ensuring Rigor in systematic reviews: part 5, quality appraisal, data extraction, synthesis. Heart Lung. 2021, 50:615-7. 10.1016\/j.hrtlng.2021.04.002","journal-title":"Heart Lung"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory mechanisms contributing to endothelial dysfunction","volume":"9","author":"Theofilis P","year":"2021","unstructured":"Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021, 9:10.3390\/biomedicines9070781","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti JS","year":"2022","unstructured":"Bhatti JS, Sehrawat A, Mishra J, et al.. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022, 184:114-34. 10.1016\/j.freeradbiomed.2022.03.019","journal-title":"Free Radic Biol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu H","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020, 126:1549-64. 10.1161\/CIRCRESAHA.119.315896","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill MA","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021, 119:154766. 10.1016\/j.metabol.2021.154766","journal-title":"Metabolism"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318061","article-title":"Arterial stiffness and cardiovascular risk in hypertension","volume":"128","author":"Boutouyrie P","year":"2021","unstructured":"Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021, 128:864-86. 10.1161\/CIRCRESAHA.121.318061","journal-title":"Circ Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.012","article-title":"Large-artery stiffness in health and disease: JACC state-of-the-art review","volume":"74","author":"Chirinos JA","year":"2019","unstructured":"Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 74:1237-63. 10.1016\/j.jacc.2019.07.012","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpz169","article-title":"Assessment of arterial stiffness in patients with resistant hypertension: Additional insights into the pathophysiology of this condition?","volume":"33","author":"Alsharari R","year":"2020","unstructured":"Alsharari R, Lip GY, Shantsila A. Assessment of arterial stiffness in patients with resistant hypertension: Additional insights into the pathophysiology of this condition?. Am J Hypertens. 2020, 33:107-15. 10.1093\/ajh\/hpz169","journal-title":"Am J Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2018-0397","article-title":"The effects of oxidative stress on the development of atherosclerosis","volume":"400","author":"Khosravi M","year":"2019","unstructured":"Khosravi M, Poursaleh A, Ghasempour G, Farhad S, Najafi M. The effects of oxidative stress on the development of atherosclerosis. Biol Chem. 2019, 400:711-32. 10.1515\/hsz-2018-0397","journal-title":"Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071408","article-title":"Role of oxidative stress in the pathogenesis of atherothrombotic diseases","volume":"11","author":"Petrucci G","year":"2022","unstructured":"Petrucci G, Rizzi A, Hatem D, Tosti G, Rocca B, Pitocco D. Role of oxidative stress in the pathogenesis of atherothrombotic diseases. Antioxidants (Basel). 2022, 11:10.3390\/antiox11071408","journal-title":"Antioxidants (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors","volume":"27","author":"Lechner K","year":"2020","unstructured":"Lechner K, von Schacky C, McKenzie AL, et al.. Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2020, 27:394-406. 10.1177\/2047487319869400","journal-title":"Eur J Prev Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13060712","article-title":"Free radicals and obesity-related chronic inflammation contrasted by antioxidants: a new perspective in coronary artery disease","volume":"13","author":"Caiati C","year":"2023","unstructured":"Caiati C, Stanca A, Lepera ME. Free radicals and obesity-related chronic inflammation contrasted by antioxidants: a new perspective in coronary artery disease. Metabolites. 2023, 13:10.3390\/metabo13060712","journal-title":"Metabolites"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124525","article-title":"Angiotensin II, hypercholesterolemia, and vascular smooth muscle cells: a perfect trio for vascular pathology","volume":"21","author":"St Paul A","year":"2020","unstructured":"St Paul A, Corbett CB, Okune R, Autieri MV. Angiotensin II, hypercholesterolemia, and vascular smooth muscle cells: a perfect trio for vascular pathology. Int J Mol Sci. 2020, 21:10.3390\/ijms21124525","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1362433","article-title":"Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database","volume":"15","author":"Ji Q","year":"2024","unstructured":"Ji Q, Chai S, Zhang R, Li J, Zheng Y, Rajpathak S. Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database. Front Endocrinol (Lausanne). 2024, 15:1362433. 10.3389\/fendo.2024.1362433","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.115207","article-title":"Impact of the co-occurrence of obesity with diabetes, anemia, hypertension, and albuminuria on concentrations of selected perfluoroalkyl acids","volume":"266","author":"Jain RB","year":"2020","unstructured":"Jain RB. Impact of the co-occurrence of obesity with diabetes, anemia, hypertension, and albuminuria on concentrations of selected perfluoroalkyl acids. Environ Pollut. 2020, 266:115207. 10.1016\/j.envpol.2020.115207","journal-title":"Environ Pollut"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08715-4","article-title":"The association between physical activity with incident obesity, coronary heart disease, diabetes and hypertension in adults: a systematic review of longitudinal studies published after 2012","volume":"20","author":"Cleven L","year":"2020","unstructured":"Cleven L, Krell-Roesch J, Nigg CR, Woll A. The association between physical activity with incident obesity, coronary heart disease, diabetes and hypertension in adults: a systematic review of longitudinal studies published after 2012. BMC Public Health. 2020, 20:726. 10.1186\/s12889-020-08715-4","journal-title":"BMC Public Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12759","article-title":"Built environment and cardio-metabolic health: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Chandrabose M","year":"2019","unstructured":"Chandrabose M, Rachele JN, Gunn L, et al.. Built environment and cardio-metabolic health: systematic review and meta-analysis of longitudinal studies. Obes Rev. 2019, 20:41-54. 10.1111\/obr.12759","journal-title":"Obes Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013479","article-title":"Trajectories of lipids profile and incident cardiovascular disease risk: a longitudinal cohort study","volume":"8","author":"Dayimu A","year":"2019","unstructured":"Dayimu A, Wang C, Li J, Fan B, Ji X, Zhang T, Xue F. Trajectories of lipids profile and incident cardiovascular disease risk: a longitudinal cohort study. J Am Heart Assoc. 2019, 8:e013479. 10.1161\/JAHA.119.013479","journal-title":"J Am Heart Assoc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab133","article-title":"Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia","volume":"106","author":"Torky A","year":"2021","unstructured":"Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, Merke DP. Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2021, 106:e5247-57. 10.1210\/clinem\/dgab133","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","article-title":"Factors associated with the occurrence of hypertension and dyslipidemia among diabetic patients attending the diabetes clinic of Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia","volume":"1","author":"Abera MA","year":"2019","unstructured":"Abera MA, Gebregziabher T, Tesfay H, Alemayehu M. Factors associated with the occurrence of hypertension and dyslipidemia among diabetic patients attending the diabetes clinic of Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia. East Afr J Health Sci. 2019, 1:3-16.","journal-title":"East Afr J Health Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/00220345231179897","article-title":"Co-occurrence of periodontitis and diabetes-related complications","volume":"102","author":"Bitencourt FV","year":"2023","unstructured":"Bitencourt FV, Nascimento GG, Costa SA, Andersen A, Sandb\u00e6k A, Leite FR. Co-occurrence of periodontitis and diabetes-related complications. J Dent Res. 2023, 102:1088-97. 10.1177\/00220345231179897","journal-title":"J Dent Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.3773","article-title":"Population-attributable risk for cardiovascular disease associated with hypertension in Black adults","volume":"4","author":"Clark D 3rd","year":"2019","unstructured":"Clark D 3rd, Colantonio LD, Min YI, et al.. Population-attributable risk for cardiovascular disease associated with hypertension in Black adults. JAMA Cardiol. 2019, 4:1194-202. 10.1001\/jamacardio.2019.3773","journal-title":"JAMA Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcy058","article-title":"Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data","volume":"5","author":"Lindh M","year":"2019","unstructured":"Lindh M, Banefelt J, Fox KM, et al.. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data. Eur Heart J Qual Care Clin Outcomes. 2019, 5:225-32. 10.1093\/ehjqcco\/qcy058","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2021.01.008","article-title":"Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: evidence from two population-based studies","volume":"42","author":"Alieva AS","year":"2020","unstructured":"Alieva AS, Olmastroni E, Reutova OV, et al.. Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: evidence from two population-based studies. Atheroscler Suppl. 2020, 42:e41-8. 10.1016\/j.atherosclerosissup.2021.01.008","journal-title":"Atheroscler Suppl"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1491149","article-title":"Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies","volume":"35","author":"Irawati S","year":"2019","unstructured":"Irawati S, Wasir R, Floriaan Schmidt A, et al.. Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies. Curr Med Res Opin. 2019, 35:291-9. 10.1080\/03007995.2018.1491149","journal-title":"Curr Med Res Opin"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi DM","year":"2020","unstructured":"Rabi DM, McBrien KA, Sapir-Pichhadze R, et al.. Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020, 36:596-624. 10.1016\/j.cjca.2020.02.086","journal-title":"Can J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04579-3","article-title":"Obesity, metabolic syndrome, and primary hypertension","volume":"36","author":"Litwin M","year":"2021","unstructured":"Litwin M, Ku\u0142aga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol. 2021, 36:825-37. 10.1007\/s00467-020-04579-3","journal-title":"Pediatr Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2019.02.009","article-title":"Clinical practice recommendations for pediatric dyslipidemia","volume":"33","author":"Elkins C","year":"2019","unstructured":"Elkins C, Fruh S, Jones L, Bydalek K. Clinical practice recommendations for pediatric dyslipidemia. J Pediatr Health Care. 2019, 33:494-504. 10.1016\/j.pedhc.2019.02.009","journal-title":"J Pediatr Health Care"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S192401","article-title":"Barriers to early diagnosis and treatment of familial hypercholesterolemia: current perspectives on improving patient care","volume":"16","author":"Alonso R","year":"2020","unstructured":"Alonso R, Perez de Isla L, Mu\u00f1iz-Grijalvo O, Mata P. Barriers to early diagnosis and treatment of familial hypercholesterolemia: current perspectives on improving patient care. Vasc Health Risk Manag. 2020, 16:11-25. 10.2147\/VHRM.S192401","journal-title":"Vasc Health Risk Manag"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2019-0552","article-title":"Definition and early diagnosis of metabolic syndrome in children","volume":"33","author":"Christian Flemming GM","year":"2020","unstructured":"Christian Flemming GM, Bussler S, K\u00f6rner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab. 2020, 33:821-33. 10.1515\/jpem-2019-0552","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100323","article-title":"Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease: An American Society for Preventive Cardiology Clinical Practice statement","volume":"10","author":"Belardo D","year":"2022","unstructured":"Belardo D, Michos ED, Blankstein R, et al.. Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease: An American Society for Preventive Cardiology Clinical Practice statement. Am J Prev Cardiol. 2022, 10:100323. 10.1016\/j.ajpc.2022.100323","journal-title":"Am J Prev Cardiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000196","article-title":"Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: A scientific statement from the American Heart Association","volume":"78","author":"Barone Gibbs B","year":"2021","unstructured":"Barone Gibbs B, Hivert MF, Jerome GJ, et al.. Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: A scientific statement from the American Heart Association. Hypertension. 2021, 78:e26-37. 10.1161\/HYP.0000000000000196","journal-title":"Hypertension"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/1559827618812395","article-title":"Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe JM","year":"2019","unstructured":"Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2019, 13:204-12. 10.1177\/1559827618812395","journal-title":"Am J Lifestyle Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey RM","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022, 328:1849-61. 10.1001\/jama.2022.19590","journal-title":"JAMA"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014168","article-title":"Lifestyle changes in relation to initiation of antihypertensive and lipid\u2010lowering medication: a cohort study","volume":"9","author":"Korhonen MJ","year":"2020","unstructured":"Korhonen MJ, Pentti J, Hartikainen J, et al.. Lifestyle changes in relation to initiation of antihypertensive and lipid\u2010lowering medication: a cohort study. J Am Heart Assoc. 2020, 9:e014168. 10.1161\/JAHA.119.014168","journal-title":"J Am Heart Assoc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac245","article-title":"Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke","volume":"43","author":"Lip GY","year":"2022","unstructured":"Lip GY, Lane DA, Lenarczyk R, et al.. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J. 2022, 43:2442-60. 10.1093\/eurheartj\/ehac245","journal-title":"Eur Heart J"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757403","article-title":"Current concepts: comprehensive \u201ccardiovascular health\u201d rehabilitation\u2014an integrated approach to improve secondary prevention and rehabilitation of cardiovascular diseases","volume":"122","author":"Buckley BJ","year":"2022","unstructured":"Buckley BJ, Lip GY. Current concepts: comprehensive \u201ccardiovascular health\u201d rehabilitation\u2014an integrated approach to improve secondary prevention and rehabilitation of cardiovascular diseases. Thromb Haemost. 2022, 122:1966-8. 10.1055\/s-0042-1757403","journal-title":"Thromb Haemost"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-021-00482-6","article-title":"Exercise training: the holistic approach in cardiovascular prevention","volume":"28","author":"Giallauria F","year":"2021","unstructured":"Giallauria F, Strisciuglio T, Cuomo G, et al.. Exercise training: the holistic approach in cardiovascular prevention. High Blood Press Cardiovasc Prev. 2021, 28:561-77. 10.1007\/s40292-021-00482-6","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpab182","article-title":"Proceedings from a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention workshop to control hypertension","volume":"35","author":"Commodore-Mensah Y","year":"2022","unstructured":"Commodore-Mensah Y, Loustalot F, Himmelfarb CD, et al.. Proceedings from a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention workshop to control hypertension. Am J Hypertens. 2022, 35:232-43. 10.1093\/ajh\/hpab182","journal-title":"Am J Hypertens"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000756","article-title":"Recommendations for cardiovascular health and disease surveillance for 2030 and beyond: a policy statement from the American Heart Association","volume":"141","author":"Roger VL","year":"2020","unstructured":"Roger VL, Sidney S, Fairchild AL, et al.. Recommendations for cardiovascular health and disease surveillance for 2030 and beyond: a policy statement from the American Heart Association. Circulation. 2020, 141:e104-19. 10.1161\/CIR.0000000000000756","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1139","article-title":"Addressing the global burden of cardiovascular diseases: need for scalable and sustainable frameworks","volume":"17","author":"Mendis S","year":"2022","unstructured":"Mendis S, Graham I, Narula J. Addressing the global burden of cardiovascular diseases: need for scalable and sustainable frameworks. Glob Heart. 2022, 17:48. 10.5334\/gh.1139","journal-title":"Glob Heart"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1253\/circrep.CR-21-0165","article-title":"Systematic review of the effectiveness of community intervention and health promotion programs for the prevention of non-communicable diseases in Japan and other East and Southeast Asian countries","volume":"4","author":"Hirashiki A","year":"2022","unstructured":"Hirashiki A, Shimizu A, Nomoto K, Kokubo M, Suzuki N, Arai H. Systematic review of the effectiveness of community intervention and health promotion programs for the prevention of non-communicable diseases in Japan and other East and Southeast Asian countries. Circ Rep. 2022, 4:149-57. 10.1253\/circrep.CR-21-0165","journal-title":"Circ Rep"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3389\/phrs.2021.1604018","article-title":"Community-based interventions for cardiovascular disease prevention in low-and middle-income countries: a systematic review","volume":"42","author":"Ndejjo R","year":"2021","unstructured":"Ndejjo R, Hassen HY, Wanyenze RK, et al.. Community-based interventions for cardiovascular disease prevention in low-and middle-income countries: a systematic review. Public Health Rev. 2021, 42:1604018. 10.3389\/phrs.2021.1604018","journal-title":"Public Health Rev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2021.09.006","article-title":"Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis","volume":"200","author":"Soltani S","year":"2021","unstructured":"Soltani S, Saraf-Bank S, Basirat R, et al.. Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis. Public Health. 2021, 200:59-70. 10.1016\/j.puhe.2021.09.006","journal-title":"Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286739-an-integrated-pathophysiological-and-clinical-perspective-of-the-synergistic-effects-of-obesity-hypertension-and-hyperlipidemia-on-cardiovascular-health-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T21:13:36Z","timestamp":1729977216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286739-an-integrated-pathophysiological-and-clinical-perspective-of-the-synergistic-effects-of-obesity-hypertension-and-hyperlipidemia-on-cardiovascular-health-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.72443","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}